Revenue of leading European pharmaceutical markets 2020
Germany was the leading pharmaceutical market in Europe with a total revenue of over 42.5 billion euros in 2020. France and Italy followed with revenues of 31.7 billion and 28 billion euros respectively. The top five were rounded off by Spain and Poland, showing the largest EU-markets.
German pharmaceutical market
When the revenue of the German pharmaceutical market is broken down, it is prescription drugs that account for the majority of the revenues. Prescription medication accounted for approximately 32 billion euros of revenue, followed by pharmacy drugs at some three billion euros.
German pharmaceutical exports
Over a fifteen-year period the value of pharmaceutical exports from Germany has skyrocketed. Increasing from approximately 18.8 billion euros in 2000 to over 87 billion euros in 2020. The leading destination for these exports is the United States with an export value of over 16 billion euros, followed by the Netherlands with a value of over eight billion euros.
German pharmaceutical market
When the revenue of the German pharmaceutical market is broken down, it is prescription drugs that account for the majority of the revenues. Prescription medication accounted for approximately 32 billion euros of revenue, followed by pharmacy drugs at some three billion euros.
German pharmaceutical exports
Over a fifteen-year period the value of pharmaceutical exports from Germany has skyrocketed. Increasing from approximately 18.8 billion euros in 2000 to over 87 billion euros in 2020. The leading destination for these exports is the United States with an export value of over 16 billion euros, followed by the Netherlands with a value of over eight billion euros.
